Atari, M. I. (Mohammed Isam), Chappell, M. J. (Michael J.), Errington, Rachel J., Smith, Paul J. (Paul James), 1953- and Evans, N. D.. (2011) Kinetic modelling of the role of the aldehyde dehydrogenase enzyme and the breast cancer resistance protein in drug resistance and transport. Computer Methods and Programs in Biomedicine, Vol.104 (No.2). pp. 93-103. ISSN 01692607

Preview

PDF WRAP_Atari_Chappell_Evans_kinetic_modelling.pdf - Accepted Version - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Download (569Kb)

Abstract

A compartmental model for the in vitro uptake kinetics of the anti-cancer agent topotecan (TPT) has been extended from a previously published model. The extended model describes the drug activity and delivery of the pharmacologically active form to the DNA target as well as the catalysis of the aldehyde dehydrogenase (ALDH) enzyme and the elimination of drug from the cytoplasm via the efflux pump. Verification of the proposed model is achieved using scanning-laser microscopy data from live human breast cancer cells. Before estimating the unknown model parameters from the experimental in vitro data it is essential to determine parameter uniqueness (or otherwise) from this imposed output structure. This is formally performed as a structural identifiability analysis, which demonstrates that all of the unknown model parameters are uniquely determined by the output structure corresponding to the experiment.

Item Type:	Journal Article
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology T Technology > TA Engineering (General). Civil engineering (General)
Divisions:	Faculty of Science > Engineering
Library of Congress Subject Headings (LCSH):	Pharmacokinetics -- Mathematical models, Aldehyde dehydrogenase, Parameter estimation, Breast -- Cancer -- Treatment -- Research
Journal or Publication Title:	Computer Methods and Programs in Biomedicine
Publisher:	Elsevier Ireland Ltd.
ISSN:	01692607
Date:	November 2011
Volume:	Vol.104
Number:	No.2
Page Range:	pp. 93-103
Identification Number:	10.1016/j.cmpb.2010.06.008
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
Version or Related Resource:	This item was also submitted to the 7th IFAC Symposium on Modelling and Control in Biomedical Systems, Aalborg, Denmark, Aug 12 - 14, 2009.
References:	Evans ND, Errington RJ, Chapman MJ, Smith PJ, Chappell MJ, Godfrey KR. Compartmental modelling of the uptake kinetics of the anti-cancer agent topotecan in human breast cancer cells. Int. J. Adapt. Control Signal Process. 2005;19:395–417 Wolfram S. The Mathematica Book (4th edn.). Mathematica Version 4. Cambridge, UK: Wolfram Media/Cambridge University Press; 1999; Bailly C. Topoisomerase I poisons and suppressors as anticancer drugs. Curr. Med. Chem. 2000;7:39–58 Garcia-Carbonero R, Supko JG. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin. Cancer Res. 2002;8:641–661 O’Leary J, Muggia FM. Camptothecins: a review of their development and schedules of administration. Eur. J. Cancer. 1998;34:1500–1508 Hsiang Y-H, Liu LF. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res. 1988;48:1722–1726 Wang JC. DNA topoisomerases. Annu. Rev. Biochem. 1996;65:635–692 Gryczynski I, Gryczynski Z, Lakowicz JR, Yang DZ, Burke TG. Fluorescence spectral properties of the anticancer drug topotecan by steady-state and frequency domain fluorometry with one-photon and multi-photon excitation. Photochem. Photobiol. 1999;69:421–428 Yao S, Murali D, Seetharamulu P, Haridas K, Petluru PNV, Reddy DG, et al. Topotecan lactone selectively binds to double- and single-stranded DNA in the absence of topoisomerase I. Cancer Res. 1998;58:3782–3786 Evans ND, Errington RJ, Shelley M, Feeney GP, Chapman MJ, Godfrey KR, et al. A mathematical model for the in vitro kinetics of the anti-cancer agent topotecan. Math. Biosci. 2004;189:185–217 Mao QC, Unadkat JD. Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J. 2005;7:E118–E133 Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomics to mechanism. Oncogene. 2003;22:7468–7485 Haimeur A, Conseil G, Deeley RG, Cole SP. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation, Curr. Drug Metab. 2004;5:21–53 Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 1998;95:15665–15670 Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 1998;58:5337–5339 Miyake K, Mickley L, Litman T, Zhan ZR, Robey R, Cristensen B, et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 1999;59:8–13 Allen JD, Schinkel AH. Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2). Mol. Cancer Ther. 2002;1:427–434 Bates SE, Robey R, Miyake K, Rao K, Ross DD, Litman T. The role of half-transporters in multidrug resistance. J. Bioenerg. Biomembr. 2001;33:503–511 Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene. 2003;22:7340–7358 Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg ACLM, Schinkel AH, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001;61:3458–3464 Scheffer GL, Maliepaard M, Pijnenborg ACLM, van Gastelen MA, de Jong MC, Schroeijers AB, et al. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. Cancer Res. 2000;60:2589–2593 Yoshida A, Rzhetsky A, Hsu LC, Chang C. Human aldehyde dehydrogenase gene family. Eur. J. Biochem. 1998;251:549–557 Deltrich RA. Tissue and subcellular distribution of mammalian aldehyde-oxidizing capacity. Biochem. Pharmacol. 1966;15:1911–1922 Yoshida A, Davé V, Han H, Scanlon KJ. Enhanced transcription of the cytosolic ALDH gene in cyclophosphamide resistant human carcinoma cells. Adv. Exp. Med. Biol. 1993;328:63–72 Moreb JS, Baker HV, Chang L-J, Amaya M, Lopez MC, Ostmark B, et al. ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells. Mol. Cancer. 2008;7:doi:10.1186/1476-4598-7-87 Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer. 2008;8:755–768 Smith PJ, Furon E, Wiltshire M, Campbell L, Feeney GP, Snyder RD, et al. ABCG2-associated resistance to Hoechst 33342 and topotecan in a murine cell model with constitutive expression of side population characteristics. Cytometry A. 2009;75A:924–933 Streltsov SA. Action models for the antitumor drug camptothecin: formation of alkali-labile complex with DNA and inhibition of human DNA topoisomerase I. J. Biomol. Struct. Dyn. 2002;20:447–454 Chen A, Moy VT. Cross-linking of cell surface receptors enhances cooperativity of molecular adhesion. Biophys. J. 2000;78:2814–2820 Heineken FG, Tsuchiya HM, Aris R. On the mathematical status of the pseudo-steady state hypothesis of biochemical kinetics. Math. Biosci. 1967;1:95–113 Chappell MJ. Structural identifiability of models characterizing saturable binding: comparison of pseudo-steady-state and non-pseudo-steady-state model formulations. Math. Biosci. 1996;133:1–20 Lineweaver H, Burk D. The determination of enzyme dissociation constants. J. Am. Chem. Soc. 1934;56:658–666 Jacquez JA. Compartmental Analysis in Biology and Medicine. 3rd edn.. Ann Arbor, MI: BioMedware; 1996; Pohjanpalo H. System identifiability based on the power series expansion of the solution. Math. Biosci. 1978;41:21–33 AEA Technology Harwell Laboratory . Facsimile (Version 4.0) Technical Reference Manual. Oxfordshire, UK: Didcot; 1995; Montgomery DC, Runger GC. Applied Statistics and Probability for Engineers. 4th edn.. Hoboken, NJ: John Wiley & Sons, Inc.; 2007; Cheung SYA, Evans ND, Chappell MJ, Godfrey KR, Smith PJ, Errington RJ. Exploration of the intercellular heterogeneity of topotecan uptake into human breast cancer cells through compartmental modelling. Math. Biosci. 2008;213:119–134
URI:	http://wrap.warwick.ac.uk/id/eprint/37147

Request changes to a record

Actions (login required)

View Item